Stay updated on EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial
Sign up to get notified when there's something new on the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page.

Latest updates to the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page
- CheckyesterdayChange DetectedThe government funding status notice banner has been removed from the page; core study details, eligibility criteria, locations, and contacts remain unchanged.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page content remained largely the same; no additions or deletions to core study details or locations were observed, and only routine timestamp updates appear. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check44 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference4%

- Check51 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now shows Revision: v3.0.2 (up from v3.0.1). The 'Back to Top' link was removed, with no other core-content changes.SummaryDifference0.2%

- Check73 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of prostate cancer has been removed from the content.SummaryDifference0.5%

Stay in the know with updates to EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page.